Upregulated expression of intermedin and its receptor in the myocardium and aorta in spontaneously hypertensive rats

Peptides

Volumn 30, Issue 2, 2009, Pages 391-399

  Zeng, Qiang ^a   Yuan, Ying ^a   Wang, Xi ^a   Wu, Hong Mei ^a   Fan, Li ^a   Qi, Yong Fen ^b   Tang, Chao Shu ^b   Cai, Yan ^b   Pan, Chun Shui ^b  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Calcitonin receptor like receptor; cAMP; Intermedin adrenomedullin 2; Receptor activity modifying proteins; Spontaneously hypertensive rats

Indexed keywords

ADRENOMEDULLIN; ADRENOMEDULLIN[22-52]; CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE[8-37]; CALCITONIN RECEPTOR LIKE RECEPTOR; CYCLIC AMP; INTERMEDIN; MESSENGER RNA; RECEPTOR ACTIVITY MODIFYING PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; CONTROLLED STUDY; HEART MUSCLE; HEART VENTRICLE HYPERTROPHY; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; UPREGULATION; VASODILATATION; WISTAR KYOTO RAT;

ADRENOMEDULLIN; ANIMALS; AORTA; HYPERTENSION; MALE; MEMBRANE PROTEINS; MYOCARDIUM; NEUROPEPTIDES; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTORS, CALCITONIN; RNA, MESSENGER; UP-REGULATION;

RATTUS;

EID: 58149505706     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2008.10.021     Document Type: Article

References (32)

1. Anderson K.M., Eckhart A.D., Willette R.N., and Koch W.J. The myocardial β-adrenergic system in spontaneously hypertensive heart failure (SHHF) rats. Hypertension 33 (1999) 402-407
2. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976) 248-254
3. Brodde O.E., Bruck H., Leineweber K., and Seyfarth T. Presence, distribution and physiological function of adrenergic and muscarinic receptor subtypes in the human heart. Basic Res Cardiol 96 (2001) 528-538
4. Burak Kandilci H., Gumusel B., Wasserman A., Witriol N., and Lippton H. Intermedin/adrenomedullin-2 dilates the rat pulmonary vascular bed: dependence on CGRP receptors and nitric oxide release. Peptides 27 (2006) 1390-1396
5. Caron K.M., and Smithies O. Extreme hydrops fetalis and cardiovascular abnormalities in mice lacking a functional Adrenomedullin gene. Proc Natl Acad Sci U S A 98 (2001) 615-619
6. Chen L., Kis B., Hashimoto H., Busija D.W., Takei Y., Yamashita H., et al. Adrenomedullin 2 protects rat cerebral endothelial cells from oxidative damage in vitro. Brain Res 1086 (2006) 42-49
7. Drake W.M., Ajayi A., Lowe S.R., Mirtella A., Bartlett T.J., and Clark A.J. Desensitization of CGRP and adrenomedullin receptors in SK-N-MC cells: implications for the RAMP hypothesis. Endocrinology 140 (1999) 533-537
8. Fischer J.A., Muff R., and Born W. Functional relevance of G-protein-coupled-receptor- associated proteins, exemplified by receptor-activity-modifying proteins (RAMPs). Biochem Soc Trans 30 (2002) 455-460
9. Fujisawa Y., Nagai Y., Miyatake A., Miura K., Shokoji T., Nishiyama A., et al. Roles of adrenomedullin 2 in regulating the cardiovascular and sympathetic nervous systems in conscious rats. Am J Physiol Heart Circ Physiol 290 (2006) H1120-1127
10. Hay D.L., Conner A.C., Howitt S.G., Smith D.M., and Poyner D.R. The Pharmacology of adrenomedullin receptors and their relationship to CGRP receptors. J Mol Neurosci 22 (2004) 105-113
11. 8-37 and BIBN4096BS. Br J Pharmacol 140 (2003) 477-486
12. Hinson J.P., Kapas S., and Smith D.M. Adrenomedullin, a multifunctional regulatory peptide. Endocr Rev 21 (2000) 138-167
13. Kaye D.M., Smirk B., Finch S., Williams C., and Esler M.D. Interaction between cardiac sympathetic drive and heart rate in heart failure modulation by adrenergic receptor genotype. J Am Coll Cardiol 44 (2004) 2008-2015
14. Kitamura K., Kato J., Kawamoto M., Tanaka M., Chino N., Kangawa K., et al. The intermediate form of glycine-extended adrenomedullin is the major circulating molecular form in human plasma. Biochem Biophys Res Commun 244 (1998) 551-555
15. Kobayashi H., Yamamoto R., Kitamura I., Niina H., Masumoto K., Minami S., et al. Cyclic AMP- dependent synthesis and release of adrenomedullin and proadrenomedullin N-terminal 20 peptide in cultured bovine adrenal chromaffin cells. Eur J Biochem 263 (1999) 702-708
16. Lopez J., and Martinez A. Cell and molecular biology of the multifunctional peptide, adrenomedullin. Int Rev Cytol 221 (2002) 1-92
17. McLatchie L.M., Fraser N.J., Main M.J., Wise A., Brown J., Thompson N., et al. RAMPs regulate the transport and ligand specificity of the calcitoninreceptor-like receptor. Nature 393 (1998) 333-339
18. Minamino N., Kangawa K., and Matsuo H. Adrenomedullin: a new peptidergic regulator of the vascular function. Clin Hemorheol Microcirc 23 (2000) 95-102
19. Mishima K., Kato J., Kuwasako K., Ito K., Imamura T., Kitamura K., et al. Effects of endothelin on adrenomedullin secretion and expression of adrenomedullin receptors in rat cardiomyocytes. Biochem Biophys Res Commun 287 (2001) 264-269
20. Morimoto R., Satoh F., Murakami O., Totsune K., Suzuki T., Sasano H., et al. Expression of adrenomedullin2/intermedin in human brain, heart, and kidney. Peptides 28 (2007) 1095-1103
21. Okumura H., Nagaya N., Itoh T., Okano I., Hino J., Mori K., et al. Adrenomedullin infusion attenuates myocardial ischemia/reperfusion injury through the phosphatidylinositol 3-kinase/Akt-dependent pathway. Circulation 109 (2004) 242-248
22. Pan C.S., Yang J.H., Cai D.Y., Zhao J., Gerns H., Yang J., et al. Cardiovascular effects of newly discovered peptide intermedin/adrenomedullin 2. Peptides 26 (2005) 1640-1646
23. Qi Y.F., Bu D.F., Niu D.D., Shi Y.R., Wang S.H., Pang Y.Z., et al. Effects of different peptide fragments derived from proadrenomedullin on gene expression of adrenomedullin gene. Peptides 23 (2002) 1141-1147
24. Roh J., Chang C.L., Bhalla A., Klein C., and Hsu S.Y. Intermedin is a calcitonin/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor/receptor activity-modifying protein receptor complexes. J Biol Chem 279 (2004) 7264-7274
25. Sexton P.M., Albiston A., Morfis M., and Tilakaratne N. Receptor activity modifying proteins. Cell Signal 13 (2001) 73-83
26. Takahashi K., Kikuchi K., Maruyama Y., Urabe T., Nakajima K., Sasano H., et al. Immunocytochemical localization of adrenomedullin - 2/intermedin-like immunoreactivity in human hypothalamus, heart and kidney. Peptides 27 (2006) 1383-1389
27. Takei Y., Inoue K., Ogoshi M., Kawahara T., Bannai H., and Miyano S. Identification of novel adrenomedullin in mammals: a potent cardiovascular and renal regulator. FEBS Lett 556 (2004) 53-58
28. Taylor M.M., and Samson W.K. Stress hormone secretion is altered by central administration of intermedin/adrenomedullin-2. Brain Res 1045 (2005) 199-205
29. Wimalawansa S.J. Amylin, calcitonin gene-related peptide, calcitonin, and adrenomedullin: a peptide superfamily. Crit Rev Neurobiol 11 (1997) 167-239
30. Yang J.H., Qi Y.F., Jia Y.X., Pan C.S., Zhao J., Yang J., et al. Tang CS Protective effects of intermedin/adrenomedullin2 on ischemia/reperfusion injury in isolated rat hearts. Peptides 26 (2005) 501-507
31. Yang J.H., Pan C.S., Jia Y.X., Zhang J., Zhao J., Pang Y.Z., et al. Intermedin1-53 activates l-arginine/nitric oxide synthase/nitric oxide pathway in rat aortas. Biochem Biophys Res Commun 341 (2006) 567-572
32. Zhao Y., Bell D., Smith L.R., Zhao L., Devine A.B., McHenry E.M., et al. Differential expression of components of the cardiomyocyte adrenomedullin/intermedin receptor system following blood pressure reduction in nitric oxide-deficient hypertension. J Pharmacol Exp Ther 316 (2006) 1269-1281